1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Colorectal
Cancer Screening and Diagnostic Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By Screening (Stool-Based Test, Colonoscopy and
Sigmoidoscopy, others)
5.2.2.
By Diagnostic (Biomarker Test, Colonoscopy)
5.2.3.
By End User (Hospitals and Clinics, Clinical
Laboratories, others)
5.2.4.
By Company (2022)
5.3.
Market Map
6. Asia Pacific Colorectal
Cancer Screening and Diagnostic Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Screening
6.2.2.
By Diagnostics
6.2.3.
By End User
6.2.4.
By Country
6.3.
Asia Pacific: Country Analysis
6.3.1.
China Colorectal Cancer Screening and Diagnostic Market
Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By
Screening
6.3.1.2.2.
By
Diagnostics
6.3.1.2.3.
By End
User
6.3.2.
India Colorectal Cancer Screening and Diagnostic Market
Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By
Screening
6.3.2.2.2.
By
Diagnostics
6.3.2.2.3.
By End
User
6.3.3.
Australia Colorectal Cancer Screening and Diagnostic
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By
Screening
6.3.3.2.2.
By
Diagnostics
6.3.3.2.3.
By End
User
6.3.4.
Japan Colorectal Cancer Screening and Diagnostic Market
Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By
Screening
6.3.4.2.2.
By
Diagnostics
6.3.4.2.3.
By End
User
6.3.5.
South Korea Colorectal Cancer Screening and Diagnostic
Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By
Screening
6.3.5.2.2.
By
Diagnostics
6.3.5.2.3.
By End
User
7. Europe Colorectal
Cancer Screening and Diagnostic Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By
Screening
7.2.2.
By
Diagnostics
7.2.3.
By End
User
7.2.4.
By Country
7.3.
Europe: Country Analysis
7.3.1.
France Colorectal Cancer Screening and Diagnostic Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By
Screening
7.3.1.2.2.
By
Diagnostics
7.3.1.2.3.
By End
User
7.3.2.
Germany Colorectal Cancer Screening and Diagnostic Market
Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By
Screening
7.3.2.2.2.
By
Diagnostics
7.3.2.2.3.
By End
User
7.3.3.
Spain Colorectal Cancer Screening and Diagnostic Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By
Screening
7.3.3.2.2.
By
Diagnostics
7.3.3.2.3.
By End
User
7.3.4.
Italy Colorectal Cancer Screening and Diagnostic Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By
Screening
7.3.4.2.2.
By
Diagnostics
7.3.4.2.3.
By End
User
7.3.5.
United Kingdom Colorectal Cancer Screening and Diagnostic
Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By
Screening
7.3.5.2.2.
By
Diagnostics
7.3.5.2.3.
By End
User
8. North America Colorectal
Cancer Screening and Diagnostic Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By
Screening
8.2.2.
By
Diagnostics
8.2.3.
By End
User
8.2.4.
By Country
8.3.
North America: Country Analysis
8.3.1.
United States Colorectal Cancer Screening and Diagnostic
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Screening
8.3.1.2.2.
By
Diagnostics
8.3.1.2.3.
By End
User
8.3.2.
Mexico Colorectal Cancer Screening and Diagnostic Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By
Screening
8.3.2.2.2.
By
Diagnostics
8.3.2.2.3.
By End
User
8.3.3.
Canada Colorectal Cancer Screening and Diagnostic Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By
Screening
8.3.3.2.2.
By
Diagnostics
8.3.3.2.3.
By End
User
9. South America Colorectal
Cancer Screening and Diagnostic Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By
Screening
9.2.2.
By Diagnostics
9.2.3.
By End
User
9.2.4.
By Country
9.3.
South America: Country Analysis
9.3.1.
Brazil Colorectal Cancer Screening and Diagnostic Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By
Screening
9.3.1.2.2.
By
Diagnostics
9.3.1.2.3.
By End
User
9.3.2.
Argentina Colorectal Cancer Screening and Diagnostic
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By
Screening
9.3.2.2.2.
By
Diagnostics
9.3.2.2.3.
By End
User
9.3.3.
Colombia Colorectal Cancer Screening and Diagnostic Market
Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By
Screening
9.3.3.2.2.
By
Diagnostics
9.3.3.2.3.
By End
User
10. Middle East and Africa
Colorectal Cancer Screening and Diagnostic Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Screening
10.2.2. By Diagnostics
10.2.3. By End User
10.2.4. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Colorectal
Cancer Screening and Diagnostic Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By
Screening
10.3.1.2.2.
By
Diagnostics
10.3.1.2.3.
By End
User
10.3.2. Saudi Arabia Colorectal
Cancer Screening and Diagnostic Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By
Screening
10.3.2.2.2.
By
Diagnostics
10.3.2.2.3.
By End
User
10.3.3. UAE Colorectal
Cancer Screening and Diagnostic Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Screening
10.3.3.2.2.
By
Diagnostics
10.3.3.2.3.
By End
User
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers & Acquisitions
13.
Global Contrast Media Agent and Injector System Market:
SWOT Analysis
14. Porter’s Five Forces
Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Product
15.
PESTLE Analysis
16.
Competitive Landscape
16.1.
Clinical Genomics Technologies Pty Ltd.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products &
Services
16.1.4. Financials (In case
of listed companies)
16.1.5. Recent Developments
16.1.6. SWOT Analysis
16.2.
Danaher Corporation
16.2.1. Business Overview
16.2.2. Company Snapshot
16.2.3. Products &
Services
16.2.4. Financials (In case
of listed companies)
16.2.5. Recent Developments
16.2.6. SWOT Analysis
16.3.
DiaCarta, Inc
16.3.1. Business Overview
16.3.2. Company Snapshot
16.3.3. Products &
Services
16.3.4. Financials (In case
of listed companies)
16.3.5. Recent Developments
16.3.6. SWOT Analysis
16.4.
Eiken Chemical Co., Ltd.
16.4.1. Business Overview
16.4.2. Company Snapshot
16.4.3. Products &
Services
16.4.4. Financials (In case
of listed companies)
16.4.5. Recent Developments
16.4.6. SWOT Analysis
16.5.
Epigenomics AG
16.5.1. Business Overview
16.5.2. Company Snapshot
16.5.3. Products &
Services
16.5.4. Financials (In case
of listed companies)
16.5.5. Recent Developments
16.5.6. SWOT Analysis
16.6.
Freenome Holdings, Inc.
16.6.1. Business Overview
16.6.2. Company Snapshot
16.6.3. Products &
Services
16.6.4. Financials (In case
of listed companies)
16.6.5. Recent Developments
16.6.6. SWOT Analysis
16.7.
Guardant Health, Inc
16.7.1. Business Overview
16.7.2. Company Snapshot
16.7.3. Products &
Services
16.7.4. Financials (In case
of listed companies)
16.7.5. Recent Developments
16.7.6. SWOT Analysis
16.8.
FUJIFILM Holdings Corporation
16.8.1. Business Overview
16.8.2. Company Snapshot
16.8.3. Products &
Services
16.8.4. Financials (In case
of listed companies)
16.8.5. Recent Developments
16.8.6. SWOT Analysis
16.9.
Novigenix SA
16.9.1. Business Overview
16.9.2. Company Snapshot
16.9.3. Products &
Services
16.9.4. Financials (In case
of listed companies)
16.9.5. Recent Developments
16.9.6. SWOT Analysis
16.10.
QuidelOrtho Corporation
16.10.1. Business Overview
16.10.2. Company Snapshot
16.10.3. Products &
Services
16.10.4. Financials (In case
of listed companies)
16.10.5. Recent Developments
16.10.6. SWOT Analysis
16.11. Olympus Corporation
16.11.1. Business Overview
16.11.2. Company Snapshot
16.11.3. Products &
Services
16.11.4. Financials (In case
of listed companies)
16.11.5. Recent Developments
16.11.6. SWOT Analysis
16.12. Lepu Medical
Technology (Beijing) Co., Ltd.
16.12.1. Business Overview
16.12.2. Company Snapshot
16.12.3. Products &
Services
16.12.4. Financials (In case
of listed companies)
16.12.5. Recent Developments
16.12.6. SWOT Analysis
17. Strategic Recommendations
18. About Us & Disclaimer